John Fair - 25 Jan 2022 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role
Chief Strategy Officer
Signature
/s/ John Fair
Issuer symbol
DARE
Transactions as of
25 Jan 2022
Transactions value $
$0
Form type
4
Filing time
28 Jan 2022, 15:05:38 UTC
Next filing
26 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DARE Stock Option (right to buy) Award $0 +185,000 $0 185,000 25 Jan 2022 Common stock 185,000 $1.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.